Literature DB >> 6361277

Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

K R Spindler, D S Rosser, A J Berk.   

Abstract

Plasmid vectors were constructed which expressed three adenovirus tumor antigens fused to a portion of the trpE protein of Escherichia coli. Insertion of adenovirus type 2 DNA from early region 1A (E1A) into such a plasmid led to a fusion protein which contained the C-terminal 266 amino acids of the 289-amino acid protein encoded by the viral 13S mRNA. Similarly, insertion of adenovirus type 5 DNA corresponding to the E1B 55- and 21-kilodalton proteins led to production of fusion proteins containing amino acid sequences from these proteins. After induction with indoleacrylic acid, fusion proteins accumulated stably in the E. coli cells. By using a simple extraction of insoluble protein, 1 to 10 mg of fusion protein per liter of culture was obtained. The fusion proteins were purified on preparative polyacrylamide gels and used to immunize rabbits. Specific antisera for the E1A 289- and closely related 243-amino acid proteins and the E1B 55- and 21-kilodalton proteins were obtained. These sera were used to immunoprecipitate the tumor antigens in cells infected with wild-type and various mutants of adenovirus or to analyze them by an immunoblotting procedure. Mutant E1A proteins in which the C-terminal 70 amino acids are deleted were phosphorylated to much lower extents than the wild-type E1A proteins. This indicates that the deleted region is important for the process of phosphorylation. The E1A proteins were extracted, sedimented in glycerol gradients, analyzed by immunoprecipitation, and found to sediment primarily as monomers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6361277      PMCID: PMC255434     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  An adenovirus type 5 early gene function regulates expression of other early viral genes.

Authors:  N Jones; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Characterization of tumor antigens in cells transformed by fragments of adenovirus type 5 DNA.

Authors:  P I Schrier; P J Van Den Elsen; J J Hertoghs; A J Van Der Eb
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

3.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

4.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

5.  Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2.

Authors:  M Green; W S Wold; K H Brackmann; M A Cartas
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

6.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

7.  The nucleotide sequence of the transforming HpaI-E fragment of adenovirus type 5 DNA.

Authors:  H Van Ormondt; J Maat; A De Waard; A J Van der Eb
Journal:  Gene       Date:  1978-12       Impact factor: 3.688

8.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

9.  In vitro translation products specified by the transforming region of adenovirus type 2.

Authors:  D N Halbert; D J Spector; H J Raskas
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

10.  Tumor antigens of human Ad5 in transformed cells and in cells infected with transformation-defective host-range mutants.

Authors:  N J Lassam; S T Bayley; F L Graham
Journal:  Cell       Date:  1979-11       Impact factor: 41.582

View more
  153 in total

1.  CHL1 is a nuclear protein with an essential ATP binding site that exhibits a size-dependent effect on chromosome segregation.

Authors:  S L Holloway
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

2.  A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.

Authors:  B Wagner; B Kropff; H Kalbacher; W Britt; V A Sundqvist; L Ostberg; M Mach
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1.

Authors:  U Müller; T Kleinberger; T Shenk
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules.

Authors:  P Flomenberg; J Szmulewicz; E Gutierrez; H Lupatkin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Development and characterization of a panel of monoclonal antibodies against the catalytic domain of the human fes proto-oncogene product.

Authors:  A van Bokhoven; H L van Duijnhoven; M Jücker; A J Roebroek; W J van de Ven
Journal:  Mol Biol Rep       Date:  1992-02       Impact factor: 2.316

6.  A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein.

Authors:  L B Holzman; R M Marks; V M Dixit
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

7.  Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.

Authors:  C M Nuebling; N Mueller-Lantzsch
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.

Authors:  D C Kaslow; I C Bathurst; T Lensen; T Ponnudurai; P J Barr; D B Keister
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product.

Authors:  Y L Lin; L A Borenstein; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  NS3 is a serine protease required for processing of hepatitis C virus polyprotein.

Authors:  L Tomei; C Failla; E Santolini; R De Francesco; N La Monica
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.